Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis

Gu, Xiuying; Zheng, Rongshou; Xia, Changfa; Zeng, Hongmei; Zhang, Siwei; Zou, Xiaonong; Yang, Zhixun; Li, He; Chen, Wanqing

doi:10.1186/s40880-018-0308-x

Table 1 Top 10 cancer incidence in three life expectancy levels areas of China, 2013

From: Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis

Rank	Gender	Low life expectancy level areas				Middle life expectancy level areas				High life expectancy level areas
		Site	Incidence	Proportion	ASR^a	Site	Incidence	Proportion	ASR^a	Site	Incidence	Proportion	ASR^a
		Site	(1/10⁵)	(%)	(1/10⁵)	Site	(1/10⁵)	(%)	(1/10⁵)	Site	(1/10⁵)	(%)	(1/10⁵)
0	Both	All sites	242.77	100.00	186.91	All sites	262.81	100.00	179.00	All sites	339.61	100.00	192.83
1		Lung	49.39	20.34	37.41	Lung	55.64	21.17	36.88	Lung	66.44	19.56	34.90
2		Stomach	37.50	15.45	28.76	Stomach	32.36	12.31	21.66	Colorectum	38.42	11.31	20.57
3		Liver	29.17	12.01	22.25	Liver	27.42	10.43	18.56	Stomach	31.83	9.37	17.08
4		Esophagus	26.87	11.07	20.58	Esophagus	24.42	9.29	16.27	Breast	56.75	8.35	34.59
5		Colorectum	17.85	7.35	13.60	Colorectum	22.61	8.60	15.12	Liver	28.08	8.27	15.83
6		Breast	28.36	5.67	21.26	Breast	37.05	6.94	25.18	Thyroid	17.54	5.16	12.19
7		Cervix	16.24	3.25	12.19	Thyroid	8.17	3.11	5.89	Esophagus	16.14	4.75	8.55
8		Brain, CNS	6.79	2.80	5.53	Cervix	14.21	2.66	9.71	Pancreas	10.16	2.99	5.21
9		Leukemia	4.83	1.99	4.46	Brain, CNS	6.21	2.36	4.63	Brain, CNS	8.81	2.59	5.82
10		Pancreas	4.03	1.66	3.06	Pancreas	6.10	2.32	4.04	Lymphoma	8.74	2.57	5.21
0	Men	All sites	276.05	100.00	220.73	All sites	294.24	100.00	207.57	All sites	365.39	100.00	209.60
1		Lung	65.90	23.87	52.32	Lung	73.76	25.07	51.26	Lung	86.09	23.56	47.22
2		Stomach	51.72	18.74	41.26	Stomach	44.90	15.26	31.41	Colorectum	43.61	11.94	24.27
3		Liver	41.18	14.92	32.42	Liver	39.91	13.56	27.97	Stomach	43.53	11.91	24.21
4		Esophagus	35.64	12.91	28.47	Esophagus	33.74	11.47	23.61	Liver	41.14	11.26	24.16
5		Colorectum	19.84	7.19	15.75	Colorectum	25.67	8.72	17.87	Esophagus	23.95	6.55	13.38
6		Brain, CNS	6.97	2.52	5.79	Bladder	7.81	2.66	5.36	Prostate	16.80	4.60	8.51
7		Bladder	5.37	1.94	4.21	Pancreas	6.95	2.36	4.83	Bladder	13.24	3.62	7.08
8		Leukemia	5.29	1.92	4.97	Prostate	6.72	2.28	4.48	Pancreas	11.26	3.08	6.13
9		Lymphoma	4.72	1.71	3.89	Lymphoma	6.17	2.10	4.53	Kidney	10.23	2.80	6.04
10		Pancreas	4.56	1.65	3.61	Leukemia	6.00	2.04	5.24	Lymphoma	9.96	2.72	6.12
0	Women	All sites	207.45	100.00	154.66	All sites	230.36	100.00	152.91	All sites	313.81	100.00	178.58
1		Lung	31.86	15.36	22.94	Breast	37.05	16.08	25.18	Breast	56.75	18.08	34.59
2		Breast	28.36	13.67	21.26	Lung	36.93	16.03	23.28	Lung	46.78	14.91	23.36
3		Stomach	22.41	10.80	16.31	Colorectum	19.46	8.45	12.51	Colorectum	33.24	10.59	17.10
4		Esophagus	17.58	8.47	12.79	Stomach	19.42	8.43	12.32	Thyroid	26.34	8.39	18.22
5		Liver	16.42	7.91	11.98	Esophagus	14.81	6.43	9.18	Stomach	20.13	6.41	10.37
6		Cervix	16.24	7.83	12.19	Liver	14.54	6.31	9.27	Cervix	15.25	4.86	9.74
7		Colorectum	15.73	7.58	11.50	Cervix	14.21	6.17	9.71	Liver	15.02	4.79	7.67
8		Uterus	7.75	3.74	5.84	Thyroid	12.74	5.53	9.12	Uterus	12.02	3.83	7.14
9		Brain, CNS	6.60	3.18	5.28	Uterus	8.31	3.61	5.66	Brain, CNS	9.71	3.09	6.18
10		Ovary	6.12	2.95	4.78	Ovary	7.26	3.15	5.11	Ovary	9.17	2.92	5.77

^aASR: age-standardized incidence rate (Segi’s Standard Population)

Back to article page

ISSN: 2523-3548

Contact us

General enquiries: info@biomedcentral.com

Cancer Communications

Contact us